DGAP-News
4SC to present at three upcoming investor conferences
DGAP-News: 4SC AG / Key word(s): Miscellaneous/Miscellaneous
4SC to present at three upcoming investor conferences
04.05.2015 / 15:46
---------------------------------------------------------------------
Announcement
4SC to present at three upcoming investor conferences
Planegg-Martinsried, Germany, 4 May 2015 - 4SC AG (Frankfurt, Prime
Standard: VSC), a discovery and development company of targeted small
molecule drugs for cancer and autoimmune diseases, will present at the
following investor conferences in May 2015:
6th DVFA Frühjahrskonferenz
Date: 6 May 2015, 11:25am CEDT
Location: Frankfurt am Main
Participant: Enno Spillner, Chairman of the Management Board (CEO & CFO) of
4SC AG
BioEquity Europe 2015
Date: 19 May 2015, 2:20pm CEDT
Location: Vienna, Austria
Participant: Enno Spillner, Chairman of the Management Board (CEO & CFO) of
4SC AG
19. MKK Münchner Kapitalmarkt Konferenz
Date: 21 May 2015, 10:40am CEDT
Location: Munich
Participant: Enno Spillner, Chairman of the Management Board (CEO & CFO) of
4SC AG
End of release
About 4SC
The Group managed by 4SC AG (ISIN DE000A14KL72) discovers and develops
targeted, small-molecule drugs for treating diseases with high unmet
medical needs in various cancer and autoimmune indications. These drugs are
intended to provide innovative treatment options that are more tolerable
and efficacious than existing therapies, and provide a better quality of
life. The Company's pipeline comprises promising products that are in
various stages of clinical development. 4SC's aim is to generate future
growth and enhance its enterprise value by entering into partnerships with
pharmaceutical and biotech companies. Founded in 1997, 4SC had a headcount
of 66 employees (57 FTEs) at 31 December 2014. 4SC AG has been listed on
the Prime Standard of the Frankfurt Stock Exchange since December 2005.
Cautionary statement regarding forward-looking statements
This press release contains certain forward-looking statements. Any
forward-looking statement applies only on the date of this press release.
By their nature, forward-looking statements are subject to a number of
known and unknown risks and uncertainties that may or may not occur in the
future and as a result of which the actual results and performance may
differ substantially from the expected future results or performance
expressed or implied in the forward looking statements. No warranties or
representations are made as to the accuracy, achievement or reasonableness
of such statements, estimates or projections, and 4SC AG has no obligation
to update any such information or to correct any inaccuracies herein or
omission herefrom which may become apparent.
For more information please visit www.4sc.com or contact:
4SC AG
Jochen Orlowski, Corporate Communications & Investor Relations
jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-6366
MC Services
Katja Arnold, Michelle Kremer
katja.arnold(at)mc-services.eu, Tel.: +49-89-2102-2840
The Trout Group
Chad Rubin
crubin(at)troutgroup.com, Tel.: +1-646-378-2947
---------------------------------------------------------------------
04.05.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: 4SC AG
Am Klopferspitz 19a
82152 Martinsried
Germany
Phone: +49 (0)89 7007 63-0
Fax: +49 (0)89 7007 63-29
E-mail: public@4sc.com
Internet: www.4sc.de
ISIN: DE000A14KL72
WKN: A14KL7
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Munich,
Stuttgart, Tradegate Exchange
End of News DGAP News-Service
---------------------------------------------------------------------
352609 04.05.2015
4SC to present at three upcoming investor conferences
Planegg-Martinsried, Germany, 4 May 2015 - 4SC AG (Frankfurt, Prime
Standard: VSC), a discovery and development company of targeted small
molecule drugs for cancer and autoimmune diseases, will present at the
following investor conferences in May 2015:
6th DVFA Frühjahrskonferenz
Date: 6 May 2015, 11:25am CEDT
Location: Frankfurt am Main
Participant: Enno Spillner, Chairman of the Management Board (CEO & CFO) of
4SC AG
BioEquity Europe 2015
Date: 19 May 2015, 2:20pm CEDT
Location: Vienna, Austria
Participant: Enno Spillner, Chairman of the Management Board (CEO & CFO) of
4SC AG
19. MKK Münchner Kapitalmarkt Konferenz
Date: 21 May 2015, 10:40am CEDT
Location: Munich
Participant: Enno Spillner, Chairman of the Management Board (CEO & CFO) of
4SC AG
End of release
About 4SC
The Group managed by 4SC AG (ISIN DE000A14KL72) discovers and develops
targeted, small-molecule drugs for treating diseases with high unmet
medical needs in various cancer and autoimmune indications. These drugs are
intended to provide innovative treatment options that are more tolerable
and efficacious than existing therapies, and provide a better quality of
life. The Company's pipeline comprises promising products that are in
various stages of clinical development. 4SC's aim is to generate future
growth and enhance its enterprise value by entering into partnerships with
pharmaceutical and biotech companies. Founded in 1997, 4SC had a headcount
of 66 employees (57 FTEs) at 31 December 2014. 4SC AG has been listed on
the Prime Standard of the Frankfurt Stock Exchange since December 2005.
Cautionary statement regarding forward-looking statements
This press release contains certain forward-looking statements. Any
forward-looking statement applies only on the date of this press release.
By their nature, forward-looking statements are subject to a number of
known and unknown risks and uncertainties that may or may not occur in the
future and as a result of which the actual results and performance may
differ substantially from the expected future results or performance
expressed or implied in the forward looking statements. No warranties or
representations are made as to the accuracy, achievement or reasonableness
of such statements, estimates or projections, and 4SC AG has no obligation
to update any such information or to correct any inaccuracies herein or
omission herefrom which may become apparent.
For more information please visit www.4sc.com or contact:
4SC AG
Jochen Orlowski, Corporate Communications & Investor Relations
jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-6366
MC Services
Katja Arnold, Michelle Kremer
katja.arnold(at)mc-services.eu, Tel.: +49-89-2102-2840
The Trout Group
Chad Rubin
crubin(at)troutgroup.com, Tel.: +1-646-378-2947
---------------------------------------------------------------------
04.05.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: 4SC AG
Am Klopferspitz 19a
82152 Martinsried
Germany
Phone: +49 (0)89 7007 63-0
Fax: +49 (0)89 7007 63-29
E-mail: public@4sc.com
Internet: www.4sc.de
ISIN: DE000A14KL72
WKN: A14KL7
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Munich,
Stuttgart, Tradegate Exchange
End of News DGAP News-Service
---------------------------------------------------------------------
352609 04.05.2015